Looking Into NeuroBo Pharmaceuticals’s Recent Short Interest
NeuroBo Pharmaceuticals's (NASDAQ:NRBO) short percent of float has fallen 47.55% since its last report. The company recently reported that it has 865 thousand shares sold short, which is 14.04% of all regular shares that are available for trading.